ScanTech AI Announces DeMeakey Williams, Sr. as Senior Vice President of Sales, Business Development, and Investor Relations
ScanTech AI (NASDAQ:STAI), a provider of AI-powered CT screening systems, has appointed DeMeakey Williams, Sr. as Senior Vice President of Sales, Business Development, and Investor Relations. Williams, who joined in April 2025, brings over 20 years of experience in scaling revenue and securing government contracts.
Prior to ScanTech AI, Williams held executive positions at Pangiam and Smiths Detection, where he secured over $500 million in contracts. He also founded Crane Consulting and Technology Solutions. The appointment aims to accelerate growth and expand ScanTech AI's presence in nuclear power markets across the U.S., Canada, and Europe.
ScanTech AI (NASDAQ:STAI), fornitore di sistemi di screening CT basati su intelligenza artificiale, ha nominato DeMeakey Williams, Sr. come Senior Vice President delle Vendite, Sviluppo Commerciale e Relazioni con gli Investitori. Williams, entrato in azienda nell'aprile 2025, vanta oltre 20 anni di esperienza nell'incremento dei ricavi e nell'ottenimento di contratti governativi.
Prima di ScanTech AI, Williams ha ricoperto ruoli dirigenziali presso Pangiam e Smiths Detection, dove ha ottenuto contratti per oltre 500 milioni di dollari. È inoltre fondatore di Crane Consulting and Technology Solutions. Questa nomina ha l'obiettivo di accelerare la crescita e ampliare la presenza di ScanTech AI nei mercati dell'energia nucleare negli Stati Uniti, Canada ed Europa.
ScanTech AI (NASDAQ:STAI), proveedor de sistemas de cribado CT impulsados por inteligencia artificial, ha nombrado a DeMeakey Williams, Sr. como Vicepresidente Senior de Ventas, Desarrollo Comercial y Relaciones con Inversionistas. Williams, quien se unió en abril de 2025, aporta más de 20 años de experiencia en el aumento de ingresos y la obtención de contratos gubernamentales.
Antes de ScanTech AI, Williams ocupó cargos ejecutivos en Pangiam y Smiths Detection, donde aseguró contratos por más de 500 millones de dólares. También fundó Crane Consulting and Technology Solutions. Este nombramiento busca acelerar el crecimiento y expandir la presencia de ScanTech AI en los mercados de energía nuclear en Estados Unidos, Canadá y Europa.
ScanTech AI (NASDAQ:STAI)� AI 기반 CT 스크리닝 시스� 제공업체�, DeMeakey Williams, Sr.� 영업, 사업 개발 � 투자� 관� 담당 수석 부사장으로 임명했습니다. Williams� 2025� 4월에 합류했으�, 20� 이상� 매출 확대 � 정부 계약 확보 경험� 보유하고 있습니다.
ScanTech AI 이전� Williams� Pangiam� Smiths Detection에서 임원직을 역임하며 5� 달러 이상� 계약� 성사시켰습니�. 또한 Crane Consulting and Technology Solutions� 설립했습니다. 이번 임명은 미국, 캐나� � 유럽� 원자� 시장에서 ScanTech AI� 성장 가속화 � 입지 확장� 목표� 합니�.
ScanTech AI (NASDAQ:STAI), fournisseur de systèmes de dépistage CT alimentés par l'IA, a nommé DeMeakey Williams, Sr. au poste de Vice-Président Senior des Ventes, du Développement Commercial et des Relations Investisseurs. Williams, qui a rejoint l'entreprise en avril 2025, possède plus de 20 ans d'expérience dans l'augmentation des revenus et l'obtention de contrats gouvernementaux.
Avant ScanTech AI, Williams a occupé des postes de direction chez Pangiam et Smiths Detection, où il a obtenu plus de 500 millions de dollars de contrats. Il est également fondateur de Crane Consulting and Technology Solutions. Cette nomination vise à accélérer la croissance et à étendre la présence de ScanTech AI sur les marchés du nucléaire aux États-Unis, au Canada et en Europe.
ScanTech AI (NASDAQ:STAI), Anbieter von KI-gestützten CT-Screening-Systemen, hat DeMeakey Williams, Sr. zum Senior Vice President für Vertrieb, Geschäftsentwicklung und Investor Relations ernannt. Williams, der im April 2025 zum Unternehmen stieß, bringt über 20 Jahre Erfahrung in Umsatzsteigerung und dem Abschluss von Regierungsverträgen mit.
Vor ScanTech AI hatte Williams Führungspositionen bei Pangiam und Smiths Detection inne, wo er Verträge im Wert von über 500 Millionen US-Dollar sicherte. Zudem gründete er Crane Consulting and Technology Solutions. Die Ernennung zielt darauf ab, das Wachstum zu beschleunigen und die Präsenz von ScanTech AI in den Kernenergiemärkten in den USA, Kanada und Europa auszubauen.
- None.
- None.
Proven Growth Strategist Joined ScanTech AI to Help Accelerate Revenue, Expand Global Market Share, and Deepen Capital Market Engagement
Atlanta, GA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: ), a next-generation provider of AI-powered CT screening systems for aviation, customs, and critical infrastructure, today announced that DeMeakey Williams, Sr. joined the Company as Senior Vice President of Sales, Business Development, and Investor Relations in April 2025.
Mr. Williams has over two decades of leadership in scaling revenue, securing high-value government contracts, and positioning technology companies for long-term capital market success. His appointment reinforces ScanTech AI’s commitment to growth, increased institutional visibility, and global brand expansion at a time of rising demand for AI-powered, U.S.-developed security screening solutions.
Prior to joining ScanTech AI in April 2025, Mr. Williams held senior executive roles at Pangiam, a national security-focused technology firm, and at Smiths Detection, a global leader in threat detection systems. Across both organizations, he played a critical role in securing more than
“I am thrilled to continue working at ScanTech AI at such a pivotal time. I believe that the Company’s platform is precisely what today’s global security landscape requires—scalable, intelligent CT technology combined with advanced AI, engineered internationally to revolutionize how nations approach trade, transportation, and threat detection,� said Mr. Williams. “I’m energized to continue driving our growth strategy, advancing stockholder value, and elevating the visibility of what I believe is one of the most disruptive AI-powered security platforms in the market—backed by potential opportunities with nuclear power prospects in the U.S., Canada, and Europe.�
About ScanTech AI
ScanTech AI Systems Inc. (Nasdaq: STAI) has developed one of the world’s most advanced non-intrusive ‘fixed-gantry� CT screening technologies. Utilizing proprietary artificial intelligence and machine learning capabilities, ScanTech AI’s state-of-the-art scanners accurately and quickly detect hazardous materials and contraband. Engineered to automatically locate, discriminate, and identify threat materials and items of interest, ScanTech AI’s solutions are designed for use in airports, seaports, borders, embassies, corporate headquarters, government and commercial buildings, factories, processing plants, and other facilities where security is a priority.
For more information, visit and .
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act�), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (“Exchange Act�), including statements regarding ScanTech AI’s management team’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion, and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Additionally, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “may,� “will,� “could,� “would,� “should,� “expect,� “intend,� “plan,� “anticipate,� “believe,� “estimate,� “predict,� “project,� “potential,� “continue,� “ongoing,� “target,� “seek� or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on the current expectations and beliefs made by the management of ScanTech AI, in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effect on ScanTech AI, as well as other factors they believe are appropriate under the circumstances. There can be no assurance that future developments affecting ScanTech AI will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including product and service acceptance, regulatory oversights, research and development success, and that ScanTech AI will have sufficient capital to operate as anticipated. Should one or more of these risks of uncertainties materialize, or should any of the assumptions of ScanTech AI prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors� and in other sections of the filings of ScanTech AI (and its predecessor, Mars Acquisition Corp.) with the U.S. Securities and Exchange Commission (the “SEC�), and in the current and periodic reports filed or furnished by ScanTech AI (and its predecessor, Mars Acquisition Corp.) from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on the information available to ScanTech AI as of the date hereof, and ScanTech AI assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may otherwise be required under applicable securities laws.
Contact:
ScanTech AI Systems Inc.
James White, CFO
Investor & Media Relations Contact:
International Elite Capital Inc.
Annabelle Zhang
+1(646) 866-7928
Attachment
